P4-BXB linear and macrocyclic HCV

Finally, the macrocyclic, P2 isoquinoline inhibitors 40 and 42 were also substantially more potent than their respective linear urea P4-BXB analogs, 44 and 45 (Figure 7.12), consistent with the generally beneficial effects of macrocyclization observed for HCV Pis. 

---